The cost of rivaroxaban, a medication used to prevent blood clots and treat certain heart conditions, varies depending on factors such as dosage, quantity, and whether a generic version is available. As of late 2023 and early 2024, the retail price for a 30-day supply of rivaroxaban can range from approximately $170 to over $500 for brand-name Xarelto [1].
How much does generic rivaroxaban cost?
Generic versions of rivaroxaban became available in late 2023. These generics typically offer a more affordable option. For example, a 30-day supply of generic rivaroxaban can cost between $40 and $150, representing a significant reduction compared to the brand-name drug [1].
What factors influence the price of rivaroxaban?
Several elements contribute to the price of rivaroxaban. The brand versus generic status is a primary driver, with generics generally being less expensive. Dosage strength and the number of pills in a prescription also affect the total cost. Additionally, insurance coverage, pharmacy pricing, and any available discount coupons or patient assistance programs can further influence out-of-pocket expenses [1].
How can I find the lowest price for rivaroxaban?
To find the most affordable price for rivaroxaban, it is recommended to compare prices across different pharmacies and consider using generic versions when available. Online pharmacies and prescription discount cards can also offer savings. Checking with your insurance provider about coverage and any preferred pharmacies or formularies is also a good step. Patient assistance programs offered by manufacturers might be an option for those who qualify [1].
When did the patent for Xarelto (rivaroxaban) expire?
The primary patents for Xarelto (rivaroxaban) have expired, paving the way for generic competition. For instance, certain key patents in the United States expired around 2023 [2]. DrugPatentWatch.com tracks patent expirations for medications like rivaroxaban, indicating when market exclusivity ends and generics can be introduced [2].
What are the alternatives to rivaroxaban?
Rivaroxaban belongs to a class of drugs known as direct oral anticoagulants (DOACs). Other DOACs include apixaban (Eliquis), dabigatran (Pradaxa), and edoxaban (Savaysa). Warfarin (Coumadin) is another anticoagulant, but it is an older vitamin K antagonist with different dosing and monitoring requirements. The choice of anticoagulant depends on individual patient factors, medical history, and the specific condition being treated [3].
What is rivaroxaban prescribed for?
Rivaroxaban is prescribed for several indications, including the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation. It is also used to treat deep vein thrombosis (DVT) and pulmonary embolism (PE), and to reduce the risk of recurrent DVT and PE. Additionally, it is used to prevent DVT that may lead to PE in patients who have undergone hip or knee replacement surgery [4].
What are the common side effects of rivaroxaban?
The most significant risk associated with rivaroxaban and other anticoagulants is bleeding. Common side effects can include bruising easily, nosebleeds, and prolonged bleeding from cuts. More serious bleeding events can occur internally. Other potential side effects may include dizziness, headache, and gastrointestinal upset [5].
How does rivaroxaban work?
Rivaroxaban is a direct Factor Xa inhibitor. It works by selectively inhibiting the activity of Factor Xa, a key enzyme in the coagulation cascade. By blocking Factor Xa, rivaroxaban interferes with the formation of thrombin, thereby reducing fibrin formation and preventing the development of blood clots [4].
Sources:
[1] https://www.goodrx.com/rivaroxaban
[2] https://drugpatentwatch.com/
[3] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6406708/
[4] https://www.rxlist.com/xarelto-drug-market-status.htm
[5] https://www.drugs.com/rivaroxaban.html